Pharma News

4 February 2026

Novo Nordisk’s CagriSema Signals a New Benchmark in Diabetes Care, Shows Edge Over Existing Therapies

Novo Nordisk has reported encouraging Phase 3 results for CagriSema, its investigational once-weekly treatment for adults with type 2 diabetes, positioning the therapy as a strong next-generation option in an increasingly competitive metabolic disease market. The findings come from the REIMAGINE-2 trial, where the combination therapy delivered superior glycaemic control and weight reduction compared to semaglutide alone.

4 February 2026

Breakthrough in HIV Vaccine Research : Single-Shot Candidate Shows Neutralizing Success in Primates

Scientists at The Wistar Institute have reported a major step forward in HIV vaccine development with a novel vaccine candidate that can induce neutralizing antibodies after a single immunization in nonhuman primates, an achievement never before demonstrated in the field.

3 February 2026

Piramal Pharma Solutions Expands Advanced Oral Drug Delivery with Tablet-in-Capsule Technology

Piramal Pharma Solutions (PPS), a global Contract Development and Manufacturing Organization (CDMO) and a part of Piramal Pharma Ltd., has strengthened its advanced dosage form portfolio with the successful development and commercialization of tablet-in-capsule drug delivery technology at its integrated drug product facilities in Pithampur and Ahmedabad, India.

3 February 2026

IPC Urges Medical Device Companies to Strengthen Adverse Event Reporting Under MvPI

The Indian Pharmacopoeia Commission (IPC), under the Ministry of Health and Family Welfare, has urged all Medical Device Marketing Authorisation Holders (MAHs) to ensure strict compliance with adverse event reporting under the Materiovigilance Programme of India (MvPI), stressing that timely reporting is critical to patient safety and effective regulatory oversight.

2 February 2026

Lupin Strengthens U.S. Oncology Portfolio with Launch of Dasatinib Tablets

Lupin Limited has launched Dasatinib Tablets in the United States, marking another significant step in expanding its oncology portfolio in the world’s largest pharmaceutical market.

2 February 2026

Budget Boost to Make India a Global Biopharma Hub

In a major push for India’s pharmaceutical and biopharmaceutical sectors, the Union Budget 2026-27, presented by Finance Minister Smt. Nirmala Sitharaman in Parliament today, announced comprehensive initiatives aimed at strengthening domestic capacity, fostering innovation and positioning India as a global biomanufacturing leader.

31 January 2026

Wearable Hydrogel Breakthrough for Real-Time Cardio & Respiration Tracking

Scientists have developed an advanced MXene-based wearable hydrogel sensor capable of continuous heart rate and respiratory monitoring under extreme conditions such as high heat, humidity and vigorous exercise.

31 January 2026

AstraZeneca taps CSPC to supercharge Obesity & Type 2 Diabetes Pipeline

AstraZeneca has entered a major collaboration with China’s CSPC Pharmaceuticals to advance the development of next-generation therapies targeting obesity and type 2 diabetes.

30 January 2026

Assam Govt Upholds Validity of Pharmacy Council Election, Council Constituted

The Government of Assam has formally upheld the validity of the Assam Pharmacy Council (APC) election held in February 2024 and confirmed the constitution of the Council, bringing an end to all disputes related to the election process.

30 January 2026

Roche Reports Strong 2025 Performance, Lifts Outlook as Pharma Sales Drive Growth

Swiss pharmaceutical and diagnostics giant Roche Group reported a strong financial performance for full-year 2025, with group sales rising 7 % at constant exchange rates, driven by solid demand for both medicines and diagnostic solutions, the company said in a media release on Thursday.

Search

Novo Nordisk’s CagriSema Signals a New Benchmark in Diabetes Care, Shows Edge Over Existing Therapies

RECOMMENDED POSTS

Subscribe with us

Jobs by Category